Leuprorelin® (LEP) is an FDA drug for breast cancer and prostate cancer treatment. There are several reported adverse effects such as transient hypertension, excessive salivation, and increased dysuria during treatment with LEP. In this study, the efficacy and toxicity of LEP were modified by using a drug delivery system to adjust the physicochemical properties. In this regard, Leuprorelin® conjugates of triphenylmethanol derivatives (TPMs) were synthesized as prodrugs. Comparative antiproliferative assays showed that LEP-TPMs conjugates had significantly higher antiproliferative activities than the corresponding non-covalent physical mixtures of the TPMs and LEP against human invasive ductal carcinoma (BT549), human prostate carcinoma (PC3), human lung cancer (A549) and mouse pre-adipocytes (3T3-L1) cells.
Introduction
Leuprorelin® (LEP) is a synthetic analogue of the gonadotropin-releasing hormone (GnRH), which was first approved by the FDA in 1985 to treat a range of sex hormone-related disorders such as precocious puberty, endometriosis, breast cancer and prostate cancer. The structure of LEP consists of nine amino acids (Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt).
Initially, LEP stimulates the pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). However, prolonged stimulation (constant concentration of LEP in the blood) of the pituitary gland How to cite this paper: Beni, R., Boadi, W., Karim, K., Alnakhli, J. and Alhamed, S. (2019) Synthesis and Antiproliferative Activities of Triphenylmethanol Conjugates of Leuprorelin. Open Journal of Medicinal Chemistry, 9, 37-47. https://doi.org /10.4236/ojmc.2019.92002 causes insensitivity to the action of GnRH. This reduces the level of gonadotropin in the blood, resulting in decreased levels of sex hormones to post-castration or menopausal levels. These effects are reversible. In addition to the usual side effects of the GnRH agonists, other reported adverse effects include transient hypertension, dry mouth, excessive salivation, paraesthesia, and increased dysuria [1] . The direct antiproliferative activity of LEP on cancer cells and improving its delivery have not been investigated.
The efficacy and toxicity of anticancer drugs can be modified by using drug delivery systems and adjusting the physicochemical properties (such as lipophilicity, cellular uptake, and prolonging activity) through chemical conjugation with various chemical moieties. The prodrug strategy is a drug delivery system through which chemical conjugation with the parent drug [2] [3] , has been widely used in the delivery of anticancer drugs such as Leuprorelin® and Dox-orubicin® [4] [5] . For example, several conjugation methods have been used to improve the delivery of Doxorubicin®, including using gold nanoparticles [6] , gold nanospheres [7] , liposomes [8] , peptides [9] - [14] , and dendrimers [15] .
However, the antiproliferative activity of LEP and its conjugation with agents who have optimal lipophilicity have not been previously reported. Herein, we investigated the anticancer activity and the development of prodrug conjugates of LEP and polyphenols to enhance the delivery of LEP.
Polyphenols are naturally occurring compounds found largely in fruits, vegetables, cereals, and beverages. Fruits like grapes, apples, pears, cherries, and berries contain up to 200 -300 mg of polyphenols per 100 grams fresh weight [16] [17] [18] . In the last decade, there has been increased interest in the potential health benefits of dietary plant polyphenols as antioxidants. The effect of polyphenols on human cancer cell lines is most often protective and induces a reduction in the number of tumors or the growth rate of tumors. These effects have been observed at various sites including the mouth, stomach, duodenum, colon, liver, lungs, mammary glands and skin. Many polyphenols, such as quercetin, catechins, isoflavones, lignans, flavanones, ellagic acid, red wine polyphenols, resveratrol, and curcumin have been tested; all of them showed protective effects in some models although their mechanisms of action were found to be different [19] [20] . Polyphenols influence the metabolism of pro-carcinogens by modulating the expression of cytochrome P450 enzymes involved in their activation of carcinogens [21] [22] .
To take advantage of the anticancer properties of polyphenolic antioxidants, several polyphenolic derivatives were chosen for conjugation with LEP. Dodecanedioic acid was selected as a lipophilic linker to attach LEP to polyphenolic derivatives. In this study, we will first report the synthesis of the antioxidant triphenylmethanol (TPMs) derivatives of LEP through the covalent conjugation with dodecanedioic acid as the linker. Second, we will report the evaluation of their in vitro cell antiproliferative activities in multiple cell lines.
In order to study cell antiproliferative activities of LEP and LEP-TPM conju- [26] . It has been estimated that about 20% of all cancers are caused by excess weight [27] . In addition to studying cancer cell lines, we also studied the anti-obesity effect of our synthesized compounds in obese mouse pre-adipocyte fibroblast cells 3T3-L1 cells.
Experimental

Preparation of TPMs 1a-e
The TPMs were synthesized using a modified method based on procedures identified in the literature [28] [29] ( Figure 1 ). Accordingly, 1,3,5-trioxane (15 mmole) was added to anisole, 2-fluoroanisole, 2-methylanisole, 1,2-dimethoxybenzene or methyl 2-methoxybenzoate (100 mmole) in 10 mL glacial acetic acid. The mixture was heated to 90˚C -95˚C, then 1 mL of sulfuric acid: glacial acetic acid (1:5, v/v) was added to the solution. The mixture was stirred for 5 hours at 90˚C -95˚C. The reaction mixture was then cooled to 0˚C using an ice bath and a homogenous solution of sodium nitrite (1.0 g, 15 mmole) and anisole, 2-fluoroanisole, 2-methylanisole, 1,2-dimethoxybenzene or methyl 2-methoxybenzoate (15 mmole) in 10 mL concentrated sulfuric acid was added to the reaction mixture. The ice bath was removed and stirring continued at room temperature for an additional 24 hours. The mixture was then poured into crushed ice (100 g 
Cell Culture
Human invasive ductal breast carcinoma (BT549), human prostate carcinoma (PC3), human lung cancer (A549) and mouse pre-adipocytes (3T3-L1) cell lines were obtained from American Type Culture Collection. The cells were grown on 75 cm 2 cell culture flasks in media consisting of 89% Dulbecco's Modified Eagle's Medium (DMEM) (GIBCO, Grand Island, NY) for pre adipocytes cell line and supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin solution (10,000 units of penicillin and 10 mg of streptomycin in 0.9 % NaCl) in a humidified atmosphere of 5% CO 2 , 95% air at 37˚C.
Antiproliferative Assay
Antiproliferative activities of synthesized LEP-TPMs 2a-e and physical mixtures of TPMs 1a-e + LEP were evaluated in BT549, PC3, A549 and 3T3-L1 cells and the results were compared with that of LEP alone. The assay was carried out using Cell Titer 96 aqueous one solution cell proliferation assay kit (Promega, 
Flow Cytometry
Human prostate carcinoma (PC3) was treated with 25 μM of LEP, 2b, 2c, and 2e for 1 h followed by 24 h incubation in drug-free medium. Cells were fixed in ice-cold ethanol: PBS (70:30, v/v) for 2 h at 4˚C, further resuspended in PBS with 100 µg/mL RNase and 40 µg/mL propidium iodide, and incubated at 37˚C for 30 min. The DNA content (for 10,000 cells) was analyzed using a FACS instrument equipped with Flowjo software (Flowjo LLC, USA). The analyses of cell cycle distribution were performed in triplicate (n = 2 plates per experiment) for the sample treatment. The coefficient of variation, according to Flowjo acquisition sotware, was always less than 5%.
Results and Discussion
Chemistry
LEP, DMSO and other chemicals and reagents were purchased from Fisher Scientific or Sigma-Aldrich Chemical Co. All coupling reactions (Figure 2) were carried out in Bio-Rad polypropylene columns by shaking and mixing using a Glass Col® small tube rotator in dry conditions at room temperature. TPMs 1a-e which are the mimics of natural poly phenolic antioxidants, were synthesized in moderate yield (Figure 1) for covalent attachment to LEP via a hydrophobic linker, dodecanedioic acid. Tris (2-(hydroxymethyl) phenol) conjugates of LEP (2a-e) with optimal hydrophobicity were synthesized to carry LEP into the cells ( Figure 2 ). All products were purified (≤95%) by a flash chromatography system and the structures of all the final compounds were confirmed by ESI/TOF mass spectrometry. Since LEP was not protected, a mixture of two phenolic and alcoholic esters was expected [30] . with cells presumably because of the higher cellular uptake. The derivatives 2a-e inhibited the cell proliferation of BT549 (22% -73%), PC3 (32% -78%), A549 (28% -69%) and 3T3-L1 (38% -72%) at a concentration of 5 -100 μM after 24 h. These data suggest that covalent conjugation of LEP-TPMs provided a more effective transporter for LEP. The antiproliferative activity of LEP-TPMs 2a-e was in the order of PC3 > BT549 > 3T3-L1 > A549. In general, the physical mixtures of TPMs 1a-e + LEP showed less antiproliferative activity after 24 hours against BT549 (7% -23%), PC3 (21% -48%), A549 (21% -43%) and 3T3-L1 (26% -42%) in comparison to covalent LEP-TPMs 2a-e. LEP exhibited similar antiproliferative activity in comparison to the physical mixture against tested cell lines after 24 h of incubation.
Antiproliferative Activity of LEP-TPMs 2a-e
Cell viability was then determined by measuring the fluorescence intensity of the product using a microplate spectrophotometer. The percentage of cell survival was calculated as OD value of cells treated with the test mixture of compounds as OD value of culture medium/(OD value of control cells-OD value of culture medium) × 100%. These data indicate that conjugation of the LEP with TPMs in compounds 2a-e significantly improved the antiproliferative activity in tested cell lines when compared with LEP and the corresponding physical mixtures. Furthermore, the compounds were also potent against 3T3-L1 cells. The mechanism of higher antiproliferative activity of these ester conjugates was presumably because of the higher cellular uptake of the TPM analogs and/or LEP since LEP alone and the corresponding physical mixture showed significantly 
Flow Cytometry
The analysis showed 3.1 -3.7 folds higher cellular uptake of LEP-TPMs than LEP alone and the physical mixtures in PC3 cells after 24 h incubation. The conjugate exhibited nuclear localization and retention after 24 hours, and underwent intracellular hydrolysis to LEP in PC3 cells.
Conclusion
In summary, LEP-TPMs derivatives were synthesized as prodrugs, evaluated for their activities against three cancer cell lines and one obese cell line and compared with the corresponding physical mixtures. The conjugation of LEP with a specific TPMs derivative improved the antiproliferative activity compared to the corresponding physical mixtures and LEP in all tested cell lines suggesting being a potential prodrug for delivery of the drug.
